Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$25.89 - $29.73 $2.6 Million - $2.99 Million
100,597 New
100,597 $2.79 Million
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $1.36 Million - $1.77 Million
32,500 New
32,500 $1.67 Million
Q2 2022

Jul 25, 2022

BUY
$46.53 - $55.17 $3.92 Million - $4.65 Million
84,204 Added 253.05%
117,480 $6.03 Million
Q1 2022

May 02, 2022

BUY
$45.75 - $56.69 $1.26 Million - $1.57 Million
27,650 Added 491.47%
33,276 $1.62 Million
Q4 2021

Jan 28, 2022

SELL
$41.32 - $61.25 $49,542 - $73,438
-1,199 Reduced 17.57%
5,626 $319,000
Q3 2021

Nov 09, 2021

SELL
$39.25 - $50.42 $3.14 Million - $4.04 Million
-80,043 Reduced 92.14%
6,825 $278,000
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $3.12 Million - $3.53 Million
86,832 Added 241200.0%
86,868 $3.4 Million
Q2 2021

Aug 09, 2021

SELL
$35.91 - $40.68 $226,628 - $256,731
-6,311 Reduced 99.43%
36 $3.4 Million
Q1 2021

May 12, 2021

SELL
$33.49 - $37.77 $7.88 Million - $8.89 Million
-235,420 Reduced 97.37%
6,347 $230,000
Q4 2020

Feb 04, 2021

BUY
$33.47 - $42.56 $1.98 Million - $2.51 Million
59,071 Added 32.33%
241,767 $8.9 Million
Q3 2020

Nov 06, 2020

BUY
$31.75 - $37.25 $5.8 Million - $6.81 Million
182,696 New
182,696 $6.71 Million
Q3 2019

Oct 29, 2019

SELL
$32.49 - $42.13 $2.07 Million - $2.68 Million
-63,700 Closed
0 $0
Q2 2019

Jul 23, 2019

BUY
$36.98 - $41.52 $2.36 Million - $2.64 Million
63,700 New
63,700 $2.76 Million
Q4 2018

Feb 11, 2019

SELL
$38.47 - $43.86 $1.9 Million - $2.17 Million
-49,505 Closed
0 $0
Q3 2018

Oct 31, 2018

SELL
$34.47 - $41.81 $26.3 Million - $31.9 Million
-761,823 Reduced 93.9%
49,505 $2.18 Million
Q2 2018

Aug 09, 2018

BUY
$32.98 - $35.16 $26.8 Million - $28.5 Million
811,328 New
811,328 $29.4 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Wbi Investments, Inc. Portfolio

Follow Wbi Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wbi Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wbi Investments, Inc. with notifications on news.